245PDDuration of response and tumor shrinkage with first-line ribociclib + letrozole in postmenopausal women with HR+, HER2– ABC
暂无分享,去创建一个
P. Ward | F. Esteva | M. Campone | T. Pluard | W. Janni | T. Bachelot | R. López | S. Sutradhar | M. Gil-Gil | Z. Král | S. Diab | E. Conejo | L. Ryvo | P. Richards | M. Auñón | T. Beck | M. Tsai | M. Miller